259868-83-2 Usage
Uses
Used in Pharmaceutical Industry:
(S)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride is used as a pharmaceutical intermediate for the development of drugs targeting neurological disorders and psychiatric conditions. Its GABAergic properties make it a promising candidate for the treatment of such conditions, as GABA is the primary inhibitory neurotransmitter in the central nervous system.
Used in Chemical Research:
(S)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride is utilized as a building block in the synthesis of other organic compounds, contributing to the advancement of chemical research and the development of novel compounds with potential applications in various fields.
Used in Drug Synthesis:
(S)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride is employed as a key component in the synthesis of new drugs, leveraging its structural features and reactivity to create innovative pharmaceutical agents with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 259868-83-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,9,8,6 and 8 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 259868-83:
(8*2)+(7*5)+(6*9)+(5*8)+(4*6)+(3*8)+(2*8)+(1*3)=212
212 % 10 = 2
So 259868-83-2 is a valid CAS Registry Number.
259868-83-2Relevant academic research and scientific papers
SUBSTITUTED PYRIMIDODIAZEPINES
-
Page/Page column 55, (2008/12/08)
The present invention provides PLK1 inhibitor compounds of formula I: Useful in the treatment or control of cell proliferative disorders, particularly oncological disorders. These compounds and formulations containing such compounds may be useful in the t
N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
-
, (2008/06/13)
This invention is directed to N-acylpyrrolidin-2-ylalkylbenzamidine derivatives which useful for inhibiting the activity of Factor Xa, by contacting said derivatives with a composition containing Factor Xa. The present invention is also directed to compositions containing said derivatives, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.
N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
-
, (2008/06/13)
This invention is directed to N-acylpyrrolidin-2-ylalkylbenzamidine derivatives which useful for inhibiting the activity of Factor Xa, by contacting said derivatives with a composition containing Factor Xa. The present invention is also directed to compos
